These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Diagnosis
39 results:

  • 1. Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling.
    Watatani Y; Sato Y; Miyoshi H; Sakamoto K; Nishida K; Gion Y; Nagata Y; Shiraishi Y; Chiba K; Tanaka H; Zhao L; Ochi Y; Takeuchi Y; Takeda J; Ueno H; Kogure Y; Shiozawa Y; Kakiuchi N; Yoshizato T; Nakagawa MM; Nanya Y; Yoshida K; Makishima H; Sanada M; Sakata-Yanagimoto M; Chiba S; Matsuoka R; Noguchi M; Hiramoto N; Ishikawa T; Kitagawa J; Nakamura N; Tsurumi H; Miyazaki T; Kito Y; Miyano S; Shimoda K; Takeuchi K; Ohshima K; Yoshino T; Ogawa S; Kataoka K
    Leukemia; 2019 Dec; 33(12):2867-2883. PubMed ID: 31092896
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Class I and II human leukocyte antibodies in pediatric haploidentical allograft candidates: prevalence and risk factors.
    Lv M; Zhai SZ; Wang Y; Xu LP; Zhang XH; Chen H; Chen YH; Wang FR; Han W; Sun YQ; Cheng YF; Yan CH; Mo XD; Liu KY; Chang YJ; Huang XJ; Zhao XY
    Bone Marrow Transplant; 2019 Aug; 54(8):1287-1294. PubMed ID: 30655602
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Effect of Heterozygosity Loss in HLA Region before Transplantation on HLA Typing in Patients with leukemia].
    Zhao JW; Wang JY; Zhang Y; Li QH; Ru K; Wang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):58-64. PubMed ID: 29397819
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia.
    Maslak PG; Dao T; Bernal Y; Chanel SM; Zhang R; Frattini M; Rosenblat T; Jurcic JG; Brentjens RJ; Arcila ME; Rampal R; Park JH; Douer D; Katz L; Sarlis N; Tallman MS; Scheinberg DA
    Blood Adv; 2018 Feb; 2(3):224-234. PubMed ID: 29386195
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. European Group for Blood and Marrow Transplantation Risk Score Predicts the Outcome of Patients with Acute leukemia Receiving Single Umbilical Cord Blood Transplantation.
    Zhu X; Huang L; Zheng C; Tang B; Liu H; Geng L; Tong J; Zhang L; Zhang X; Yao W; Song K; Wang X; Ding K; Sun Z
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2118-2126. PubMed ID: 28807768
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Are changes in HLA Ags responsible for leukemia relapse after HLA-matched allogeneic hematopoietic SCT?
    Hamdi A; Cao K; Poon LM; Aung F; Kornblau S; Fernandez Vina MA; Champlin RE; Ciurea SO
    Bone Marrow Transplant; 2015 Mar; 50(3):411-3. PubMed ID: 25621795
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation.
    Morishima Y; Kawase T; Malkki M; Morishima S; Spellman S; Kashiwase K; Kato S; Cesbron A; Tiercy JM; Senitzer D; Velardi A; Petersdorf EW;
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1197-203. PubMed ID: 23747601
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Diagnostic utility of HFE variants in Spanish patients: association with HLA alleles and role in susceptibility to acute lymphoblastic leukemia.
    Rodríguez-López R; Donoso M; Fernández-Cavada M; González LM; Margallo A; Corral C; Gallego M; García de Cáceres MT; Herrera T; González C; Vagace JM; Gervasini G
    Gene; 2013 Feb; 514(1):31-5. PubMed ID: 23178241
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy.
    Dubois V; Sloan-Béna F; Cesbron A; Hepkema BG; Gagne K; Gimelli S; Heim D; Tichelli A; Delaunay J; Drouet M; Jendly S; Villard J; Tiercy JM
    Leukemia; 2012 Sep; 26(9):2079-85. PubMed ID: 22488219
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Optimised radiological diagnosis of hepatic fungal infection during the treatment of leukemia.
    Petrausch U; Frauenfelder T; Mueller NJ; Arn K; Stussi G; Schanz U
    Mycoses; 2012 Sep; 55(5):447-53. PubMed ID: 22320220
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. KIR molecules: recent patents of interest for the diagnosis and treatment of several autoimmune diseases, chronic inflammation, and B-cell malignancies.
    De Re V; Caggiari L; De Zorzi M; Toffoli G
    Recent Pat DNA Gene Seq; 2011 Dec; 5(3):169-74. PubMed ID: 21787272
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia.
    Lodewyck T; Oudshoorn M; van der Holt B; Petersen E; Spierings E; von dem Borne PA; Schattenberg A; Allebes W; Groenendijk-Sijnke M; Duinhouwer L; Willemze R; Lowenberg B; Verdonck LF; Meijer E; Cornelissen JJ
    Leukemia; 2011 Oct; 25(10):1548-54. PubMed ID: 21606965
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Autologous hematopoietic stem cell transplantation-what determines the outcome: an experience from North India.
    Kumar L; Malik PS; Prakash G; Prabu R; Radhakrishnan V; Katyal S; Hariprasad R
    Ann Hematol; 2011 Nov; 90(11):1317-28. PubMed ID: 21409382
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
    Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
    Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Limits of HLA mismatching in unrelated hematopoietic cell transplantation.
    Petersdorf EW; Anasetti C; Martin PJ; Gooley T; Radich J; Malkki M; Woolfrey A; Smith A; Mickelson E; Hansen JA
    Blood; 2004 Nov; 104(9):2976-80. PubMed ID: 15251989
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors.
    Locatelli F; Zecca M; Messina C; Rondelli R; Lanino E; Sacchi N; Uderzo C; Fagioli F; Conter V; Bonetti F; Favre C; Porta F; Giorgiani G; Pession A
    Leukemia; 2002 Nov; 16(11):2228-37. PubMed ID: 12399966
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Successful reduced-intensity stem cell transplant from one-locus HLA-mismatched unrelated cord blood after rejection of unrelated bone marrow in an infant with myelogenous leukemia.
    Shibuya A; Kaneko I; Ishii S; Sasaki N
    Hematology; 2002 Apr; 7(2):101-3. PubMed ID: 12186699
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Determinants of survival after human leucocyte antigen-matched unrelated donor bone marrow transplantation in adults.
    Barker JN; Davies SM; DeFor TE; Burns LJ; McGlave PB; Miller JS; Weisdorf DJ
    Br J Haematol; 2002 Jul; 118(1):101-7. PubMed ID: 12100132
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation.
    Weisdorf DJ; Anasetti C; Antin JH; Kernan NA; Kollman C; Snyder D; Petersdorf E; Nelson G; McGlave P
    Blood; 2002 Mar; 99(6):1971-7. PubMed ID: 11877268
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.